Skip to main content
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;13(1):34–37. doi: 10.1111/j.1750-3639.2003.tb00004.x

Green Fluorescent Protein Immunohistochemistry as a Novel Experimental Tool for the Detection of Glioma Cell Invasion In Vivo

David Zagzag 1,2,3,4,6,, Douglas C Miller 2,3,4,6, Luis Chiriboga 5,6, Herman Yee 3,5,6, Elizabeth W Newcomb 3,6
PMCID: PMC8095779  PMID: 12580543

Abstract

In vivo animal models of primary brain tumors are necessary to advance knowledge related to the complex interactions between glioma cells and the adjacent brain. A cardinal feature of glioma growth, and a major reason why neurosurgical and adjunctive therapies ultimately fail in most patients is their invasive properties. We have adapted a previously described animal model developed by one of us to give better histological detail while preserving the identification of single infiltrating glioma cells. GL261 glioma cells were first transfected with the plasmid encoding green fluorescent protein (GFP) and then implanted into the brains of syngeneic C57BL/6 mice. Identification of GFP‐positive tumor cells in paraffin sections of the brains of tumorbearing animals utilized an antibody for conventional immunoperoxidase immunohistochemistry. This method is a more powerful technique compared with the prior use of frozen sections and fluorescence microscopy to identify GFP‐tagged tumor cells. We find that this new method provides improved morphology and proves to be a sensitive and reliable system for detection of invading glioma cells. Using this methodology with other advanced technologies (eg, laser capture microdissection) holds out the promise of helping to elucidate the molecular mechanisms of glioma cell infiltration and invasion into the surrounding brain.

Full Text

The Full Text of this article is available as a PDF (403.5 KB).

References

  • 1. Chishima T, Moyagi Y, Wang X, Yamaoka H, Shimada H, Moossa AR, Hoffman RM (1997) Cancer invasion and micrometastasis visualised in live tissue by green fluorescent protein expression. Cancer Res 57:2047–2077. [PubMed] [Google Scholar]
  • 2. Hochberg FH, Pruitt A (1980) Assumptions in the radiotherapy of glioblastoma. Neurology 30:907–911. [DOI] [PubMed] [Google Scholar]
  • 3. Jung S, Ackerley C, Ivanchuk S, Mondal S, Becker LE, Rutka JT (2001) Tracking the invasiveness of human astrocytoma cells by using green fluorescent protein in an organotypical brain slice model. J Neurosurg 94:80–89. [DOI] [PubMed] [Google Scholar]
  • 4. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215–225. [DOI] [PubMed] [Google Scholar]
  • 5. Scherer HJ (1938) Structural development in gliomas. Am J Cancer 34:333–351. [Google Scholar]
  • 6. Zagzag D, Amirnovin R, Greco MA, Yee H, Holash J, Wiegand S, Zabski S, Yancopoulos GD, Grumet M (2000) Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis. Lab Invest 80:837–849. [DOI] [PubMed] [Google Scholar]
  • 7. Zagzag, D , Shiff B, Jallo GI, Greco MA, Hukin J, Allen JC, Friedlander DR (2002) Tenascin‐C promotes microvascular migration and phosphorylation of focal adhesion kinase. Cancer Res 62:2660–2668. [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES